文章摘要
中华预防医学会.中国脑膜炎球菌疫苗预防接种专家共识[J].中华流行病学杂志,2019,40(2):123-128
中国脑膜炎球菌疫苗预防接种专家共识
Experts' consensus on immunization with meningococcal vaccines in China
投稿时间:2018-12-28  
DOI:10.3760/cma.j.issn.0254-6450.2019.02.001
中文关键词: 流行性脑脊髓膜炎;脑膜炎奈瑟菌;脑膜炎球菌疫苗;共识
英文关键词: Meningococcal meningitis;Neisseria meningitidis;Meningococcal vaccine;Consensus
基金项目:
作者单位
中华预防医学会  
摘要点击次数: 311
全文下载次数: 293
中文摘要:
      中国上市的脑膜炎球菌疫苗包括脑膜炎球菌多糖疫苗、脑膜炎球菌多糖结合疫苗和联合疫苗,不同生产企业的脑膜炎球菌多糖结合疫苗的免疫程序有所不同,给实际接种工作带来困扰。本共识结合国内外研究最新进展,基于流行性脑脊髓膜炎流行特征、脑膜炎奈瑟菌菌群分布以及中国脑膜炎球菌疫苗免疫原性和安全性等研究证据,提出脑膜炎球菌疫苗预防接种建议,供预防接种人员和疾病预防控制机构人员参考使用。
英文摘要:
      Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine, meningococcal polysaccharide conjugate vaccine, and a combined vaccine. Meningococcal conjugate vaccines immunization schedules vary by vaccine manufacturer, and often cause confusion in immunization practices. Based on the epidemiological characteristics of meningococcal disease, serogroup distribution of Neisseria meningitidis, and research progress on the immunogenicity and safety of meningococcal vaccines, we developed an experts' consensus on immunization with meningococcal vaccines to provide guidance for immunization providers and for centers for disease control and prevention staff.
查看全文   Html全文     查看/发表评论  下载PDF阅读器
关闭